SAN FRANCISCO--(BUSINESS WIRE)--StemLifeLine, a Bay Area-based life sciences company, announced today that under its new partnership agreements, three United States fertility clinics, the Fertility Laboratories of Colorado (FLC), the Nevada Center for Reproductive Medicine (NCRM) and the Idaho Center for Reproductive Medicine (ICRM), will now offer individuals who have undergone in vitro fertilization (IVF) the opportunity to use StemLifeLine’s service to develop personal stem cell lines from their unused, stored embryos. StemLifeLine is the first company to offer this unique service.
